Coronavirus vaccine update: Russia says its corona vaccine is ready for use



In a major breakthrough, the early-stage human trial data has revealed that the coronavirus vaccine candidate developed by AstraZeneca and Oxford University is safe. German biotech firm BioNTech and US drugmaker Pfizer also reported that their experimental Covid-19 vaccine was safe and induced an immune response in patients. The latest developments raise hope as these could contribute to ending the pandemic, which has infected over 14.7 million people worldwide and claimed over 600,000 lives so far. More than 150 possible vaccines are being developed and tested around the world, including in India, Britain, China, the US, Russia and Israel to try to stop the pandemic. At present, 23 vaccine candidates are in human clinical trials. These include those of Moderna, AstraZeneca Plc, BioNTech, Novavax, Sinovac, CanSino Biologics and Inovio Pharmaceuticals.

Coronavirus treatment: Updates on coronavirus vaccine/drug development:

1. Russia claims its coronavirus vaccine is ready for use

A Covid-19 vaccine developed with the Russian Defense Ministry completed Phase 2 trials, leading First Deputy Defense Minister Ruslan Tsalikov to say the first domestic inoculation is ready for use.

Comments

Popular posts from this blog

Infinix Smart 2 review: 'Value for money' smartphone with tall 18:9 screen

Year in review: From OnePlus to Asus, best midrange flagship phones of 2019

OnePlus 8 review: Meaningful innovations elevate experience, justify price